Milnacipran and venlafaxine at flexible doses (up to 200 mg/day) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomized, double-blind exploratory study

Jean-Pierre Olié, David Gourion, Agnès Montagne, et al

Neuropsychiatric Disease and Treatment 2010, 6:71-79

Published Date: 23 March 2010